-
Immune Organoid Company Raises $4.3M in Seed Funds
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds.
-
Personal Allergy Start-Up Gains $16.5M in Early Funds
A new business that provides personalized allergy testing, drug making, and delivery to consumers is raising $16.5 million in its first venture funding round.
-
Trial Shows Gel Clears Common Skin Cancer Wounds
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors.
-
Bye-Bye Bluebird
In mid-November we removed our Twitter feed display in the right-hand column. Yesterday, we decided to leave Twitter altogether.
-
Brain-Computer Interface Company Raises $75M in New Funds
A developer of an implanted electronic system that captures and transmits thoughts of movement into signals for digital devices is raising $75 million in venture funds.
-
Trial Testing Ultrasound for Brain Cancer Liquid Biopsies
A clinical trial is underway testing the safety and feasibility of focused ultrasound to enable use of blood tests to monitor a patient’s glioblastoma, a form of brain cancer.
-
New Company Creating High-Capacity Gene Therapies to the Brain
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders.
-
Mental Health VR Companies Merge, Raise $13M
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds.
-
Bone Regeneration Experiment Begun on Space Station
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station.
-
Infographic – U.S. Majorities Support Clinical Trials
A solid majority of Americans adults consider it very important to conduct clinical trials, even if it takes longer to develop new treatments for disease.